Author:
Concannon Kyle F.,Glisson Bonnie S.,Doebele Robert C.,Huang Chao,Marotti Marcelo,Camidge D.Ross,Heymach John V.
Reference47 articles.
1. Cancer statistics, 2024;Siegel;CA Cancer J Clin,2024
2. Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology;Ganti;J Natl Compr Canc Netw,2021
3. Treatment of extensive small cell lung cancer;Davies;Hematol Oncol Clin North Am,2004
4. Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial;Paz-Ares;Lancet,2019
5. Amit Ramesh Mohindra, Mohammad Razaq et al. Randomized phase II clinical trial of cisplatin/carboplatin and etoposide (CE) alone or in combination with nivolumab as frontline therapy for extensive-stage small cell lung cancer (ES-SCLC): ECOG-ACRIN EA5161;Leal;Journal of Clinical Oncology,2020